Analysen von Michael Leuchten

09.09.20		AstraZeneca Sell	UBS AG
02.09.20		Roche buy	UBS AG
18.08.20		Novo Nordisk Neutral	UBS AG
11.08.20		Roche buy	UBS AG
07.08.20		Merck Neutral	UBS AG
06.08.20		Novo Nordisk Neutral	UBS AG
04.08.20		Bayer buy	UBS AG
31.07.20		Sartorius vz. Sell	UBS AG
Werbung
30.07.20		Roche buy	UBS AG
27.07.20		Roche buy	UBS AG
23.07.20		Roche buy	UBS AG
22.07.20		Bayer buy	UBS AG
21.07.20		Sartorius vz. Sell	UBS AG
21.07.20		AstraZeneca Sell	UBS AG
20.07.20		Novo Nordisk Neutral	UBS AG
16.07.20		Sartorius vz. Sell	UBS AG
10.07.20		Bayer buy	UBS AG
09.07.20		Bayer buy	UBS AG
08.07.20		Bayer buy	UBS AG
01.07.20		Bayer buy	UBS AG
25.06.20		Sartorius vz. Sell	UBS AG
25.06.20		Bayer buy	UBS AG
23.06.20		Bayer buy	UBS AG
15.06.20		Bayer buy	UBS AG
10.06.20		Bayer buy	UBS AG
08.06.20		AstraZeneca Sell	UBS AG
08.06.20		Sartorius vz. Sell	UBS AG
05.06.20		Novo Nordisk Neutral	UBS AG
05.06.20		Bayer buy	UBS AG
04.06.20		AstraZeneca Sell	UBS AG
27.05.20		AstraZeneca Sell	UBS AG
25.05.20		AstraZeneca Sell	UBS AG
22.05.20		AstraZeneca Sell	UBS AG
14.05.20		Novo Nordisk Neutral	UBS AG
14.05.20		Roche buy	UBS AG
14.05.20		Merck Neutral	UBS AG
13.05.20		Roche buy	UBS AG
11.05.20		Novo Nordisk Neutral	UBS AG
06.05.20		Novo Nordisk buy	UBS AG
29.04.20		AstraZeneca Sell	UBS AG
28.04.20		Roche buy	UBS AG
27.04.20		Bayer buy	UBS AG
23.04.20		Roche buy	UBS AG
22.04.20		Sartorius vz. Neutral	UBS AG
17.04.20		Novo Nordisk buy	UBS AG
15.04.20		Novo Nordisk buy	UBS AG
24.03.20		Roche buy	UBS AG
23.03.20		Novo Nordisk buy	UBS AG
10.03.20		Merck Neutral	UBS AG
09.03.20		AstraZeneca Sell	UBS AG